Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

B Cantin1, F Gagnon, S Moorjani

  • 1Lipid Research Centre, Laval University Medical Centre and Faculty of Medicine, Laval University, Ste-Foy, Quebec, Canada. CLajoie@sympatico.ca

Insights

Lipoprotein(a) [Lp(a)] did not independently predict ischemic heart disease (IHD). However, elevated Lp(a) appeared to worsen risks from other lipid factors like LDL cholesterol.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • Elevated lipoprotein(a) [Lp(a)] concentrations are suspected risk factors for ischemic heart disease (IHD).
  • Previous research findings are inconsistent, and few studies have been prospective.

Purpose of the Study:

  • To determine if lipoprotein(a) [Lp(a)] is an independent risk factor for ischemic heart disease (IHD).
  • To examine the relationship between Lp(a) and other lipid fractions in predicting IHD risk.

Main Methods:

  • A 5-year prospective follow-up of 2,156 French Canadian men aged 47-76 without existing IHD.
  • Baseline measurements included total cholesterol, LDL, HDL, apoprotein B, and Lp(a).
  • Adjusted proportional hazards models analyzed IHD event risks and Lp(a) interactions with lipid factors.

Main Results:

  • Lipoprotein(a) [Lp(a)] was not identified as an independent risk factor for ischemic heart disease (IHD).
  • Elevated Lp(a) appeared to amplify the adverse effects of high LDL cholesterol, total cholesterol, and apoprotein B.
  • Elevated Lp(a) seemed to diminish the protective effects of high HDL cholesterol.

Conclusions:

  • In this cohort, lipoprotein(a) [Lp(a)] is not an independent predictor of ischemic heart disease (IHD).
  • Lp(a) may modify the risk associated with other established lipid risk factors, potentially increasing overall cardiovascular risk.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...